Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review
JM Malinowski, S Bolesta - Clinical therapeutics, 2000 - Elsevier
Objective: This article reviews the pharmacology, pharmacokinetics, clinical efficacy,
adverse effects, drug interactions, and dosing of rosiglitazone, the second thiazolidinedione
approved for the treatment of type 2 diabetes mellitus. Methods: Background information for
this article was obtained from searches of MEDLINE®, Iowa Drug Information Service, and
International Pharmaceutical Abstracts, as well as from data on file with the manufacturer of
rosiglitazone. Results: Rosiglitazone is indicated for use alone or in combination with …
adverse effects, drug interactions, and dosing of rosiglitazone, the second thiazolidinedione
approved for the treatment of type 2 diabetes mellitus. Methods: Background information for
this article was obtained from searches of MEDLINE®, Iowa Drug Information Service, and
International Pharmaceutical Abstracts, as well as from data on file with the manufacturer of
rosiglitazone. Results: Rosiglitazone is indicated for use alone or in combination with …